GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » CompuGroup Medical SE & Co KgaA (XTER:COP) » Definitions » Debt-to-EBITDA

CompuGroup Medical SE KgaA (XTER:COP) Debt-to-EBITDA : 6.17 (As of Dec. 2024)


View and export this data going back to 2007. Start your Free Trial

What is CompuGroup Medical SE KgaA Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

CompuGroup Medical SE KgaA's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was €54 Mil. CompuGroup Medical SE KgaA's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was €826 Mil. CompuGroup Medical SE KgaA's annualized EBITDA for the quarter that ended in Dec. 2024 was €143 Mil. CompuGroup Medical SE KgaA's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2024 was 6.17.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for CompuGroup Medical SE KgaA's Debt-to-EBITDA or its related term are showing as below:

XTER:COP' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 1.79   Med: 3.16   Max: 4.27
Current: 4.27

During the past 13 years, the highest Debt-to-EBITDA Ratio of CompuGroup Medical SE KgaA was 4.27. The lowest was 1.79. And the median was 3.16.

XTER:COP's Debt-to-EBITDA is ranked worse than
68.94% of 454 companies
in the Healthcare Providers & Services industry
Industry Median: 2.38 vs XTER:COP: 4.27

CompuGroup Medical SE KgaA Debt-to-EBITDA Historical Data

The historical data trend for CompuGroup Medical SE KgaA's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CompuGroup Medical SE KgaA Debt-to-EBITDA Chart

CompuGroup Medical SE KgaA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.88 3.46 3.45 3.60 4.25

CompuGroup Medical SE KgaA Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.89 3.20 3.82 3.94 6.17

Competitive Comparison of CompuGroup Medical SE KgaA's Debt-to-EBITDA

For the Health Information Services subindustry, CompuGroup Medical SE KgaA's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CompuGroup Medical SE KgaA's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, CompuGroup Medical SE KgaA's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where CompuGroup Medical SE KgaA's Debt-to-EBITDA falls into.


;
;

CompuGroup Medical SE KgaA Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

CompuGroup Medical SE KgaA's Debt-to-EBITDA for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(53.553 + 826.439) / 206.904
=4.25

CompuGroup Medical SE KgaA's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(53.553 + 826.439) / 142.708
=6.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2024) EBITDA data.


CompuGroup Medical SE KgaA  (XTER:COP) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


CompuGroup Medical SE KgaA Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of CompuGroup Medical SE KgaA's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


CompuGroup Medical SE KgaA Business Description

Traded in Other Exchanges
Address
Maria Trost 21, Koblenz, DEU, 56070
CompuGroup Medical SE & Co KgaA provides electronic health solutions to healthcare providers through the following segments: Ambulatory information systems, Pharmacy information systems, and Hospital information systems. The Ambulatory information systems segment, which generates maximum revenue, focuses on developing and selling practice management software for registered physicians and medical care centers. This segment offers comprehensive end-to-end solutions that cover all essential clinical, administrative, and billing functions. In addition, its portfolio includes data-driven products, software interfaces for information exchange, medical decision support tools, and pharmaceutical and therapy databases, among other solutions. The company mainly operates in the U.S. and Europe.
Executives
Daniela Hommel CFO, Managing director of the general partner of the issuer
Michael Rauch Managing director of the general partner of the issuer
Emanuele Mugnani Managing director of the general partner of the issuer
Frank Gotthardt Chairman of Administrative Board of CompuGroup Medical Management SE
Prof. (apl.) Dr. Med Daniel Gotthardt Member of the Administrative Board of CompuGroup Medical Management SE
Hannes Reichl Managing director of the general partner of the issuer
Dr. Eckart Pech Managing director of the general partner of the issuer
Dr. Dirk Wössner CEO, Managing director of the general partner of the issuer
Dr. Ralph Körfgen Managing director of the general partner of the issuer